Adenoviral-mediated Gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice
- 1 September 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (14), 2135-2142
- https://doi.org/10.1016/j.ejca.2004.05.006
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapyBritish Journal of Surgery, 2002
- Targeting Angiogenesis and HGF Function Using an Adenoviral Vector Expressing the HGF Antagonist NK4 for Cancer TherapyMolecular Therapy, 2002
- Kringle 1–4 of Hepatocyte Growth Factor Inhibits Proliferation and Migration of Human Microvascular Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomesGene Therapy, 2000
- Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal disseminationInternational Journal of Cancer, 1996
- Mode of Recurrence after Gastric Cancer SurgeryDigestive Surgery, 1994
- Aberrant expression of c‐met mRNA in human gastric carcinomasInternational Journal of Cancer, 1993
- Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodentsCancer, 1993
- Frequent amplification of the c-met gene in scirrhous type stomach cancerBiochemical and Biophysical Research Communications, 1992
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984